160 related articles for article (PubMed ID: 19789207)
1. Hypogonadism risk in men treated for childhood cancer.
Romerius P; Ståhl O; Moëll C; Relander T; Cavallin-Ståhl E; Wiebe T; Giwercman YL; Giwercman A
J Clin Endocrinol Metab; 2009 Nov; 94(11):4180-6. PubMed ID: 19789207
[TBL] [Abstract][Full Text] [Related]
2. High risk of hypogonadism in young male cancer survivors.
Isaksson S; Bogefors K; Ståhl O; Eberhard J; Giwercman YL; Leijonhufvud I; Link K; Øra I; Romerius P; Bobjer J; Giwercman A
Clin Endocrinol (Oxf); 2018 Mar; 88(3):432-441. PubMed ID: 29245176
[TBL] [Abstract][Full Text] [Related]
3. Gonadal status in male survivors following childhood brain tumors.
Schmiegelow M; Lassen S; Poulsen HS; Schmiegelow K; Hertz H; Andersson AM; Skakkebaek NE; Müller J
J Clin Endocrinol Metab; 2001 Jun; 86(6):2446-52. PubMed ID: 11397837
[TBL] [Abstract][Full Text] [Related]
4. The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males.
Moreno-Pérez O; Escoín C; Serna-Candel C; Portilla J; Boix V; Alfayate R; González-Sánchez V; Mauri M; Sánchez-Payá J; Picó A
J Sex Med; 2010 Aug; 7(8):2873-83. PubMed ID: 20626606
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of androgen deficiency and abnormal lipid profile in infertile men with non-obstructive azoospermia.
Bobjer J; Naumovska M; Giwercman YL; Giwercman A
Int J Androl; 2012 Oct; 35(5):688-94. PubMed ID: 22519695
[TBL] [Abstract][Full Text] [Related]
6. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.
Nord C; Bjøro T; Ellingsen D; Mykletun A; Dahl O; Klepp O; Bremnes RM; Wist E; Fosså SD
Eur Urol; 2003 Sep; 44(3):322-8. PubMed ID: 12932930
[TBL] [Abstract][Full Text] [Related]
7. Gonadal function in young adult males with metabolic syndrome.
Choudhury BK; Choudhury SD; Saikia UK; Sarma D
Diabetes Metab Syndr; 2013; 7(3):129-32. PubMed ID: 23953176
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
9. Hypogonadism and fertility issues following primary treatment for testicular cancer.
Oldenburg J
Urol Oncol; 2015 Sep; 33(9):407-12. PubMed ID: 25736189
[TBL] [Abstract][Full Text] [Related]
10. Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome.
Bogefors C; Isaksson S; Bobjer J; Kitlinski M; Leijonhufvud I; Link K; Giwercman A
Andrology; 2017 Jul; 5(4):711-717. PubMed ID: 28544654
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
Sprauten M; Brydøy M; Haugnes HS; Cvancarova M; Bjøro T; Bjerner J; Fosså SD; Oldenburg J
J Clin Oncol; 2014 Feb; 32(6):571-8. PubMed ID: 24419125
[TBL] [Abstract][Full Text] [Related]
12. Do male lymphoma survivors have impaired sexual function?
Kiserud CE; Schover LR; Dahl AA; Fosså A; Bjøro T; Loge JH; Holte H; Yuan Y; Fosså SD
J Clin Oncol; 2009 Dec; 27(35):6019-26. PubMed ID: 19858388
[TBL] [Abstract][Full Text] [Related]
13. Hypogonadism in male patients with cancer.
Garcia JM; Li H; Mann D; Epner D; Hayes TG; Marcelli M; Cunningham GR
Cancer; 2006 Jun; 106(12):2583-91. PubMed ID: 16688773
[TBL] [Abstract][Full Text] [Related]
14. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
Lackner JE; Märk I; Schatzl G; Marberger M; Kratzik C
Urology; 2007 Apr; 69(4):754-8. PubMed ID: 17445664
[TBL] [Abstract][Full Text] [Related]
15. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome.
Radicioni AF; Di Giorgio G; Grugni G; Cuttini M; Losacco V; Anzuini A; Spera S; Marzano C; Lenzi A; Cappa M; Crinò A
Clin Endocrinol (Oxf); 2012 Jan; 76(1):72-7. PubMed ID: 21718342
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study.
Greenfield DM; Walters SJ; Coleman RE; Hancock BW; Eastell R; Davies HA; Snowden JA; Derogatis L; Shalet SM; Ross RJ
J Clin Endocrinol Metab; 2007 Sep; 92(9):3476-82. PubMed ID: 17579201
[TBL] [Abstract][Full Text] [Related]
17. Reproductive status in adult male long-term survivors of childhood cancer.
Tromp K; Claessens JJ; Knijnenburg SL; van der Pal HJ; van Leeuwen FE; Caron HN; Beerendonk CC; Kremer LC
Hum Reprod; 2011 Jul; 26(7):1775-83. PubMed ID: 21489977
[TBL] [Abstract][Full Text] [Related]
18. Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors.
Ekedahl H; Isaksson S; Ståhl O; Bogefors K; Romerius P; Eberhard J; Giwercman A
BMC Cancer; 2022 Feb; 22(1):157. PubMed ID: 35135482
[TBL] [Abstract][Full Text] [Related]
19. Testosterone and gonadotropin levels in men with dementia.
Hogervorst E; Combrinck M; Smith AD
Neuro Endocrinol Lett; 2003; 24(3-4):203-8. PubMed ID: 14523358
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH.
Bruheim K; Svartberg J; Carlsen E; Dueland S; Haug E; Skovlund E; Tveit KM; Guren MG
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):722-7. PubMed ID: 18262088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
